GlycoFree is a tablet sold for blood-sugar support at $69 a bottle ($59/bottle for three, $49 for six) with a 90-day money-back guarantee — all verified directly on its sales page. What that page never provides, anywhere, is an ingredient list: no supplement-facts panel, no ingredient names, nothing. Its headline also makes a disease-specific claim ("#1 formula to support your type II diabetes health goals") that supplement rules don't permit. Evidence rating: 1.0/5. Product Fit Score: 2.9/5.
GlycoFree
- Form
- tablet
- Price
- $69 (1 bottle) · $59/bottle (3) · $49/bottle (6)
- Guarantee
- 90-day money-back (stated by seller)
- Sold via
- buygoods_or_direct
- Label amounts
- None disclosed — sales page shows no ingredient list at all (verified 2026-09-01)
✓ 90-day refund window stated by seller — long enough to run an honest self-trial
Check current price on the seller's site
Affiliate link. Prices and guarantee as shown on the seller's page on 1 September 2026; they may have changed. Not independently verified beyond that page.
Evidence & product fit
| Product Fit factor | Score (out of 5) | Why |
|---|---|---|
| Formula completeness | 1.0 | A supplement page with confirmed pricing and zero ingredient disclosure is the lowest transparency configuration that exists. |
| Ease of use | 4.5 | The tablet format is generally straightforward, but clear serving directions were not available in the product facts we verified. |
| Guarantee & buying terms | 4.5 | 90 days confirmed on the page — genuinely long for the category, and the product's one strong feature. |
| Price / value | 1.5 | $49–69 per bottle for undisclosed contents cannot be priced against anything. |
| Category relevance | 3.0 | The category match is weak or difficult to verify with blood sugar support positioning. Category relevance measures fit to the intended use; it does not mean the finished product has been clinically proven effective. |
Might suit you if…
- {'Honestly': 'no one, until the maker publishes a label — there is no configuration of buyer for whom undisclosed contents are the right choice in a glucose product'}
Skip it if…
- Anyone on diabetes medication — unknown ingredients mean unassessable interaction and hypoglycemia risk, full stop
- Anyone comparing blood-sugar supplements on evidence — the berberine-class products at least name and dose their contents
- Anyone drawn by the diabetes claim in the headline — that phrasing itself marks a seller ignoring the rules that protect you
The Evidence Rating reflects research on the finished product and/or named ingredients for the intended use. The Product Fit Score is a separate practical assessment of formula completeness, ease of use, guarantee/buying terms, price/value and category relevance. Neither score is a customer rating, and affiliate relationships do not determine either score. See the full scoring method.
What we verified, and what's missing
We reviewed GlycoFree's sales page directly on 2026-09-01. Confirmed on the page: tablet format, pricing at $69 / $59 / $49 per bottle across single, three and six-bottle bundles, and a 90-day money-back guarantee. Also on the page: the headline claim to be the "#1 formula to support your type II diabetes health goals" — supplement rules prohibit disease-specific claims, and the label guide's character test applies: a seller's relationship with that rule predicts everything else.
Missing from the page, entirely: the ingredients. No supplement-facts image, no ingredient names in the copy, no "key ingredients" section, nothing. In three years of grading this aisle's tricks — proprietary blends, fairy-dust doses — full non-disclosure remains the rare configuration that ends analysis at the door.
Why non-disclosure decides everything
Every honest question a glucose-supplement buyer has routes through the label. Does it work? — evidence belongs to named ingredients at studied doses; no names, no evidence, even in principle. Is it safe with my medication? — glucose-active compounds add to drug effects and several (berberine most famously) alter drug metabolism; a secret formula is an unscreenable one, which for the medicated diabetic reader is a genuine hazard rather than a scoring quibble. Is $69 fair? — against what? Named-and-dosed competitors at least submit to comparison.
The 90-day guarantee earns its 4.5 — it is the longest in our blood-sugar set after Gluco Extend's 180 — and it cannot rescue the rest, because a refund window is compensation for risk, not a substitute for knowing what you swallowed for three months.
Verdict
2.0/5 — the guarantee, and nothing else to score. If you want a blood-sugar supplement, the evidence page ranks what named ingredients actually show, and every product we've reviewed with a visible label — whatever its score — offers more than this one by the act of disclosure itself. If you have diabetes, the treatment that actually moves A1C was never in this aisle. We'll re-review the day GlycoFree publishes a panel.
Frequently asked questions
Does GlycoFree lower blood sugar?
Unanswerable — and that is the review. Evidence belongs to ingredients at doses, and GlycoFree discloses neither. No claim on its page can be checked against a single trial, which places it below products whose named ingredients merely test weakly.
Is it safe to take with metformin or insulin?
Unknowable, which for practical purposes means no. Glucose-active compounds stack with medication (hypoglycemia risk) and several common ones affect drug metabolism. With contents undisclosed, neither you nor your prescriber can assess it — and a pharmacist can't screen a secret.
The page mentions a 90-day guarantee — is that real?
The guarantee statement and the pricing were the parts we could verify directly on the page (2026-09-01 check). Ninety days is long for this category. Whether refunds are honored as described is a different question we can't verify; keep order confirmation and payment records if you test it.
What would change this review?
A published supplement-facts panel. If GlycoFree discloses its label, we will re-review against the same standard as every product here — ingredient by ingredient, dose against trials. Until then the score reflects what a buyer actually faces: a sealed box with a diabetes claim on it.
A blood-sugar product with no ingredient list — what's the specific danger beyond wasted money?
Silent pharmacology stacking. The glucose-supplement grab bag (berberine, gymnema, cinnamon, chromium, bitter melon) contains members that genuinely nudge glucose and interact with diabetes medication — which means an undisclosed formula taken alongside metformin, sulfonylureas or insulin adds an unmeasurable variable to a system people dose carefully. Hypoglycemia from stacking is a real emergency-department presentation, and 'natural' contributes nothing to the triage. The rule for this aisle is absolute in a way it isn't elsewhere: no disclosure, no purchase — and anything that does disclose still merits a prescriber conversation before it shares a shelf with glucose medication.
GlycoFree — from $69 · 90-day seller refund window
Check current price on the seller's site Compare blood sugar support supplements
Affiliate links. Our evaluation is unaffected — the criterion scores above explain the verdict either way.
References
- National Center for Complementary and Integrative Health (NCCIH). Diabetes and Dietary Supplements: What You Need To Know (2021). https://www.nccih.nih.gov/health/diabetes-and-dietary-supplements-what-you-need-to-know
- U.S. Food and Drug Administration. Dietary Supplements (2024). https://www.fda.gov/food/dietary-supplements
- Federal Trade Commission. FTC Endorsement Guides (2023). https://www.ftc.gov/business-guidance/resources/ftcs-endorsement-guides-what-people-are-asking
Dietary supplements do not treat diabetes or prediabetes and should not replace prescribed medication, glucose monitoring, diet or activity. Some ingredients can lower glucose or interact with diabetes medicines, increasing the risk of hypoglycemia. If you use insulin or glucose-lowering medication, discuss the formula with your clinician or pharmacist before starting it.